Skip to main content

Milestone Scientific Inc.

corporate_fare Company Profile

Milestone Scientific Inc.

MLSS·NYSE·Industrial Applications And Services·CIK 0000855683

Milestone Scientific Inc. develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company was incorporated in the State of Delaware in August 1989. The company's core technology platform, Dynamic Pressure Sensing® ("DPS") Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. In the dental market, the company's products are marketed under the CompuDent® and STA Single Tooth Anesthesia System® trademarks and utilize The Wand®, a single-use disposable handpiece. These products are sold in the United States, Canada, and more than 40 other countries. The company describes its CompuDent® System, first marketed as the Wand® and the first computer-controlled local anesthesia delivery (C-CLAD) system, as the market leader in dental injection technology. In the medical market, the company has received U.S. Food and Drug Administration ("FDA") 510(k) clearance for its CompuFlo® Epidural Computer Controlled Anesthesia System for use in specified regions of the spine. The company's CompuFlo® Computer-Controlled Drug Delivery System with DPS Dynamic Pressure Sensing Technology is described as an advanced technology for the painless and accurate delivery of drugs, anesthetics, and other medicaments into all tissue types, as well as for the aspiration of bodily fluids or previously injected substances. The company continues to evaluate opportunities to expand its distribution channels, including e-commerce and third-party distributor relationships, and to pursue additional regulatory clearances and commercial opportunities in domestic and international markets.

Milestone Scientific Inc. (NYSE:MLSS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for MLSS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Recent SEC coverage for MLSS spans 10-Q.

Recent high-impact activity:

  • Milestone Scientific Q3 Loss Narrows but Going-Concern Doubt Persists; NYSE Listing Deadline April 8, 2027

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$8.97M
Net Income
-$5.72M
Diluted EPS
-$0.07
Op. Cash Flow
-$2.92M
Free Cash Flow
-$2.93M
Gross Profit
$6.41M
Operating Income
-$5.7M
Cash & Equivalents
$1.11M
Debt / Equity
0.00×
Net Margin
-63.8%
Shares Outstanding
80.45M sh
Source: 10-K · filed 2026-05-05 · accession 0001493152-26-021293

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 78,756 shares in MLSS as of the October 30, 2026 settlement, a 3.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 18.2% of MLSS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)78,756 shares as of October 30, 2026
Change vs prior period▼ 3.0%
Days to cover1.00 at avg daily volume of 102,865
Daily short volume (FINRA facilities)18.2% of 73,107 shares on November 20, 2026
5-day average short volume19.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.24
52-week range · as of 2026-11-13 $0.2181 – $0.5796
Market cap
$21.75M
Volume
108.8K (1.0× avg)
3-mo avg 111.8K
Live data · 2026-11-21 04:35 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed MLSS - Latest Insights

MLSS
Nov 13, 2026, 7:30 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3158
Real-time Price: $0.240 info
Change: -$0.0758 (-24%) info
Market Cap: $21.747M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets